66435-201 : Infergen .03 mg/ml Subcutaneous Injection

Labeler: Kadmon Pharmaceuticals, LLC
Product Type: Human Prescription Drug
Drug Name:  Infergen
Dosage Form: Subcutaneous Injection
Application #: BLA103663
Rev. Date: 

NDC Package Codes:

  • 66435-201-15: 6 VIAL, SINGLE‑DOSE IN 1 PACKAGE (66435‑201‑15) > .5 ML IN 1 VIAL, SINGLE‑DOSE (66435‑201‑96)

Active Ingredients:

  • Interferon Alfacon-1

Dosage Strength:

  • .03 mg/mL

Pharmaceutical Classes:

  • Interferon alpha [EPC]
  • Interferon-alpha [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 66435-202 Infergen .03 mg/ml Subcutaneous Injection by Kadmon Pharmaceuticals, LLC


Scan the QR code below to easily reference this data in the future:

NDC 66435-201 QR Code

< Prev: 66435-108Next: 66435-202 >

Related Discussions:

Is there some place to get financial help purchasing interferon? ## 877 447 3243 ask for patient assistance plan - they ... 1 reply
Pegylated Interferon
What are the long-term side effects of pegylated interferon? I'm having a lot of symptoms I can't explain. ## He... 2 replies
Combined Methotextrate and Interferon usage.
Hi all, I'm interested in your opinions on this. I have MS.I also have rather severe Psoriasis. PA got pretty damn a... 1 reply
long term aftereffects of pegysus interferon
Four yes.post tx hepc. Feel worse than before tx ## Hello, Jerry! How are you doing? What types of symptoms are you havi... 1 reply

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA